FdaApplication
ANDA 213859
Identifiers
- fda_app_no: ANDA213859
Properties
| Property | Value |
|---|---|
| applicant_name | GUANGZHOU NOVAKEN PHARM CO LTD |
| application_type | ANDA |
| approval_date | 2020-11-18 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| ESOMEPRAZOLE MAGNESIUM | ESOMEPRAZOLE MAGNESIUM | EQ 20MG BASE | CAPSULE, DELAYED REL PELLETS;ORAL |
| ESOMEPRAZOLE MAGNESIUM | ESOMEPRAZOLE MAGNESIUM | EQ 40MG BASE | CAPSULE, DELAYED REL PELLETS;ORAL |
2 products